| Growth Factor Receptor Family | 
                Description | 
              
                | Epidermal Growth Factor Receptors 
                   (EGFR)  | 
                ERBB - Frequently found to be overexpressed in 
                  several tumor types glioblastomas, head/neck squamous cell carcinomas, 
                  breast, oesophageal, urogenital and colorectal tumors.  
                  Experimentation has shown that the antisense approach can reverse the 
                  tumorgenicity of a colon carcinoma cell line. 
                   ERBB-2 - Found in carcinomas of the breast, ovaries, colon, lung, 
                  liver, stomach, kidneys, oesophagus, salivery gland and bladder.  
                  Amplification of ERBB2 occurs in 20% invasive breast carcinomas.  It 
                  increases the growth rate of breast carcinomas but not their metastatic 
                  potential. 
                  ERBB-3 - High expression of ERBB3 correlated with the presence of lymph 
                  node metastasis. 
                   ERBB-4  | 
              
                | Insulin Like Receptors 
                   (InsulinR)  | 
                IGFI - Primary Breast Tumors express high 
                  levels of IGFI receptor.  Antisense RNS to the IGFI receptor was 
                  shown to inhibit growth of human melanoma and glioma in nude mice.  
                  In the absence of IGFI receptor a large fraction of cells may die through 
                  apoptosis, preventing efficient tumor growth. 
                   IRR, Ros, Ltk  | 
              
                | Platelet-Derived Growth Factor Receptors 
                   (PDGFR)  | 
                PDGF alpha and beta - glioblastomas, chronic 
                  myelomonocytic leukaemia. 
                   c-KIT/SCFR - (Stem Cell Factor Receptor)  GIST 
                  CSF1 - Found in patients with myelodysplastic syndrome. 
                   Flk2/Flt3  | 
              
                | Fibroblast Growth Factor Receptors 
                   (FGFR)  | 
                FGFR-1,FGFR-2, FGFR-3, FGFR-4, Cek2 | 
              
                | Neurotrophin Receptor Family | 
                  | 
              
                | Angiogenic Receptors | 
                The growth of solid tumors is absolutely 
                  dependent on angiogenesis.  Some tumor cells can release angiogenic 
                  factors but others recruit macrophages.  Angiostatin is produced by 
                  certain tumors and inhibits angiogenesis. 
                   FGF - binds to a family of receptors with two or three immunoglobuline 
                  like extracellular domains.  Overexpression contributes to growth of 
                  melanomas and some breast cancers.. 
                  VEGF - binds to 2 related receptors with seven immunoglobulin like 
                  extracellular domains.  | 
              
                | Hepatocyte Growth Factor Receptor | 
                MET - Osteosarcoma, Colorectum, thyroid, 
                  ovaries, stomach, pancreas and hepatocellular carninomas. | 
              
                | Cytokine Receptor Family | 
                  |